In the News
<< Back2018
July 2018
In two PhIII wins for Allergan/Molecular Partners, wet AMD drug shows non-inferiority to Lucentis
2017
October 2017
We are using cookies in order to facilitate your navigation on this website. You can read about how we use cookies and how to manage them here. By continuing to navigate on this website or clicking on the button, you accept our cookie notice and related Privacy Policy.
I accept the use of cookies